Sigyn Therapeutics, Inc. (SIGY)
OTCMKTS · Delayed Price · Currency is USD
0.4705
0.00 (0.00%)
At close: Jan 21, 2026
Sigyn Therapeutics Market Cap
Sigyn Therapeutics has a market cap or net worth of $802.69 thousand as of January 23, 2026. Its market cap has decreased by -96.23% in one year.
Market Cap
802.69K
Enterprise Value
3.53M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.47
Market Cap Chart
Since October 20, 2020, Sigyn Therapeutics's market cap has decreased from 66.98M to 802.69K, a decrease of -98.80%. That is a compound annual growth rate of -56.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 802.69K | -70.76% |
| Dec 16, 2025 | 2.75M | -45.72% |
| Dec 17, 2024 | 5.06M | -16.78% |
| Dec 27, 2023 | 6.08M | -4.15% |
| Dec 29, 2022 | 6.34M | -66.00% |
| Dec 30, 2021 | 18.65M | -57.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evofem Biosciences | 1.10M |
| CERo Therapeutics Holdings | 1.02M |
| Lipella Pharmaceuticals | 993.48K |
| Emmaus Life Sciences | 982.64K |
| EV Biologics | 829.28K |
| Protagenic Therapeutics | 829.00K |
| Regen BioPharma | 756.38K |
| Windtree Therapeutics | 711.25K |